These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 3887396

  • 1. Conversion from cyclosporine to prednisolone and azathioprine. Safe or unsafe?
    Adu D, Michael J, Vlassis T, McMaster P.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():998-1001. PubMed ID: 3887396
    [Abstract] [Full Text] [Related]

  • 2. The use of cyclosporine only in cadaveric renal transplant recipients: conversion to prednisolone and azathioprine after four months.
    Tegzess AM, Donker AJ, Meijer S, van Son WJ, van Woude FJ, Slooff MJ, Fidler VJ, Sluiter WJ, van der Slikke LB.
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():992-7. PubMed ID: 3887395
    [Abstract] [Full Text] [Related]

  • 3. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months.
    Morris PJ, French ME, Dunnill MS, Hunnisett AG, Ting A, Thompson JF, Wood RF.
    Transplantation; 1983 Sep; 36(3):273-7. PubMed ID: 6310833
    [Abstract] [Full Text] [Related]

  • 4. Conversion of immunosuppression in renal allograft recipients from cyclosporine A to azathioprine and prednisolone 6 months after transplantation.
    Lennard TW, Venning M, Donnelly PK, Wilson RG, Parrott NR, Elliott RW, Proud G, Farndon JR, Ward MK, Wilkinson R.
    Transplant Proc; 1987 Oct; 19(5):3594-6. PubMed ID: 3313866
    [No Abstract] [Full Text] [Related]

  • 5. Triple drug immunosuppression (cyclosporine, azathioprine and low-dose prednisolone): a safe and effective regimen in first-cadaver kidney transplantation.
    Mourad G, Legendre C, Argiles A, Bonardet A, Mion C.
    Transplant Proc; 1987 Oct; 19(5):3672-3. PubMed ID: 3313886
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine.
    Hall BM, Tiller DJ, Hardie I, Mahony J, Mathew T, Thatcher G, Miach P, Thomson N, Sheil AG.
    N Engl J Med; 1988 Jun 09; 318(23):1499-507. PubMed ID: 3285215
    [Abstract] [Full Text] [Related]

  • 7. Selective conversion from azathioprine to cyclosporin for steroid-resistant rejection in renal transplants: an alternative therapy.
    Crowson MC, Berisa F, McGonigle RJ, Adu D, Michael J, Barnes AD.
    Nephrol Dial Transplant; 1989 Jun 09; 4(2):129-32. PubMed ID: 2496354
    [Abstract] [Full Text] [Related]

  • 8. Conversion of long-term renal allograft recipients from prednisolone/azathioprine to cyclosporine monotherapy.
    Birkeland SA, Foged N, Kold AA, Svendsen V, Rohr N, Elbirk A.
    Transplant Proc; 1988 Jun 09; 20(3 Suppl 3):171-5. PubMed ID: 3291237
    [No Abstract] [Full Text] [Related]

  • 9. Fine-needle aspiration cytology monitoring of elective conversion from cyclosporin to azathioprine and prednisolone.
    Ubhi CS, Baker JM, Guillou PJ, Giles GR, Davison AM, Will EJ.
    Nephrol Dial Transplant; 1988 Jun 09; 3(4):453-7. PubMed ID: 3140133
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppression with a combination of cyclosporin, azathioprine, and prednisolone may be unsafe.
    Salaman JR, Griffin PJ.
    Lancet; 1985 Nov 09; 2(8463):1066-7. PubMed ID: 2865541
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclosporine treatment with conversion after three months is a safe treatment protocol in renal allograft recipients.
    Hoitsma AJ, Tiggeler RG, Wetzels JF, Berden JH, Koene RA.
    Transplant Proc; 1988 Jun 09; 20(3 Suppl 3):161-3. PubMed ID: 3291234
    [No Abstract] [Full Text] [Related]

  • 15. Randomized prospective trial of elective cyclosporine withdrawal from triple therapy at 6 months after cadaveric renal transplantation.
    Hiesse C, Neyrat N, Deglise-Favre A, Lantz O, Bensadoun H, Benoit G, Charpentier B, Fries D.
    Transplant Proc; 1991 Feb 09; 23(1 Pt 2):987-9. PubMed ID: 1989354
    [No Abstract] [Full Text] [Related]

  • 16. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM, White DJ, Thiru S, Evans DB, Calne RY.
    N Engl J Med; 1984 Jan 19; 310(3):148-54. PubMed ID: 6361559
    [Abstract] [Full Text] [Related]

  • 17. [Results of conversion from conventional immunosuppressive therapy to cyclosporin A in complications following kidney transplantation].
    Scholz D, Blank W, Bärwolf C, Ditscherlein G, Christenfeld R, Hüller H.
    Z Urol Nephrol; 1990 Feb 19; 83(2):69-76. PubMed ID: 2368516
    [Abstract] [Full Text] [Related]

  • 18. Conversion from cyclosporine to azathioprine in renal allograft recipients.
    Rocher LL, Milford EL, Kirkman RL, Carpenter CB, Strom TB, Tilney NL.
    Transplantation; 1984 Dec 19; 38(6):669-74. PubMed ID: 6390830
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of steroids in cyclosporine-treated renal transplant recipients.
    Griffin PJ, Da Costa CA, Salaman JR.
    Transplantation; 1987 Apr 19; 43(4):505-8. PubMed ID: 3554643
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine mono-drug therapy.
    Salaman J.
    Transplant Proc; 1988 Jun 19; 20(3 Suppl 3):117-20. PubMed ID: 3291223
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.